Drug Discovery Chemistry is a dynamic conference for medicinal, biophysical, and computational chemists working across pharma, biotech, and academia. Focused on discovery and optimization challenges of small-molecule and macrocyclic drug candidates, the 2026 event convened 850 attendees and featured sessions spanning AI- and ML-driven design, fragment- and structure-based discovery, molecular glues and degraders, DNA-encoded libraries, and emerging biophysical tools..
Speaker participation by industry was very strong, with presentations from AbbVie, Amgen, Astex Pharmaceuticals, AstraZeneca, Bayer, Eli Lilly, Genentech, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, and numerous emerging biotechs. On-demand registration is now available if you’d like to catch up on the symposia, tracks, and plenaries.